Use of CD38 Antibodies in High-Risk Newly Diagnosed Multiple Myeloma: A Meta-Analysis

Clinical Lymphoma Myeloma & Leukemia 2026 Open access

Read full text

Authors: Divaya Bhutani, Yusha Katie Liu, Rajshekhar Chakraborty, Michael Sang Hughes, Suzanne Lentzsch, Samuel M. Rubinstein

DOI: 10.1016/j.clml.2026.04.016

Cited by: 0

References: 16

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Peptidase Inhibition and Analysis Monoclonal and Polyclonal Antibodies Research

References 16